Login to Your Account



Financings Roundup

Novavax Publicly Raising $18M To Fund Avian Flu Vaccine Work

By Jennifer Boggs


Thursday, November 3, 2005
Capitalizing on its rising stock price driven by avian flu fears, Novavax Inc. is bringing in $18 million through a public offering to support clinical development. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription